Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Down – Here’s Why

Posted by Andrew Walz on May 26th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $11.84, but opened at $11.06. Fresenius SE & Co. shares last traded at $11.0450, with a volume of 18,359 shares.

Analyst Ratings Changes

A number of research firms recently weighed in on FSNUY. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research note on Monday, April 20th. Citigroup restated a “buy” rating on shares of Fresenius SE & Co. in a research report on Tuesday, February 3rd. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, Fresenius SE & Co. has an average rating of “Buy”.

Read Our Latest Stock Analysis on FSNUY

Fresenius SE & Co. Price Performance

The company has a current ratio of 1.32, a quick ratio of 1.00 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $24.90 billion, a P/E ratio of 14.73 and a beta of 0.68. The business’s fifty day moving average price is $12.43 and its 200-day moving average price is $13.67.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). The company had revenue of $6.75 billion for the quarter, compared to the consensus estimate of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.29% and a net margin of 6.55%. As a group, sell-side analysts predict that Fresenius SE & Co. will post 1.05 earnings per share for the current fiscal year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.